Filter by keywords:



Filtering documents. Please wait...

1/3. Juxtacortical osteogenic sarcoma of mandible. A case report.

    Juxtacortical osteogenic sarcoma of bone is a relatively uncommon form of osteogenic sarcoma. In the jaw bones, it is extremely rare. Here, we present a case of Juxtacortical Osteogenic Sarcoma of mandible in a 45 year old man which presented as an epulis in the mandibular incisor region.
- - - - - - - - - -
ranking = 1
keywords = mandible, jaw
(Clic here for more details about this article)

2/3. osteosarcoma of the jaws in children.

    Two cases of osteosarcoma of the jaws in children are reported. One patient was a 13-year-old girl whose first symptoms included nasal and maxillary sinus congestion, followed by epistaxis. She was found to have chondroblastic osteosarcoma extending through the left maxillary alveolar process and sinus. Following surgery and chemotherapy, the patient has been free of disease for 7 years. The second patient, an 8-year-old boy, was diagnosed with juxtacortical (parosteal) osteosarcoma of the mandible, which is a less aggressive variant of the neoplasm. It is believed that this is the youngest patient reported to date with juxtacortical osteosarcoma of the jaws. He was treated by block resection of the right side of the mandible and is free of disease 3(1/2) years later.
- - - - - - - - - -
ranking = 0.54913180536962
keywords = mandible, jaw
(Clic here for more details about this article)

3/3. Periosteal osteosarcoma of the mandible.

    A case of periosteal osteosarcoma of the mandibular premolar region in a 20-year-old woman is described. The tumor was excised, and 5 years later the patient shows no evidence of disease. This is probably the second documented case of periosteal osteosarcoma of the mandible reported.
- - - - - - - - - -
ranking = 0.97336932046971
keywords = mandible
(Clic here for more details about this article)


Leave a message about 'Osteosarcoma, Juxtacortical'


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.